Human Biospecimens Market Size to Hit USD 26.45 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Human Biospecimens Market

5.1. COVID-19 Landscape: Human Biospecimens Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Human Biospecimens Market, By Specimen Type

8.1. Human Biospecimens Market Revenue and Volume, by Specimen Type

8.1.1. Tissue Specimens

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Biofluids

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Cellular Material

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Nucleic Acids

8.1.4.1. Market Revenue and Volume Forecast

Chapter 9. Global Human Biospecimens Market, By Application

9.1. Human Biospecimens Market Revenue and Volume, by Application

9.1.1. Cancer Research

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Drug Discovery and Development

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Diagnostics and Biomarker Discovery

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Translational and Genomic Research

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Precision Medicine

9.1.5.1. Market Revenue and Volume Forecast

9.1.6. Infectious Disease Studies (e.g., COVID-19, HIV, TB)

9.1.6.1. Market Revenue and Volume Forecast

9.1.7. Neurology and Cardiovascular Research

9.1.7.1. Market Revenue and Volume Forecast

Chapter 10. Global Human Biospecimens Market, By End Use

10.1. Human Biospecimens Market Revenue and Volume, by End Use

10.1.1. Pharmaceutical and Biotechnology Companies

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Contract Research Organizations (CROs)

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Academic and Research Institutes

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Hospitals and Biobanks

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Diagnostic Laboratories

10.1.5.1. Market Revenue and Volume Forecast

10.1.6. Government & Non-Profit Organizations

10.1.6.1. Market Revenue and Volume Forecast

Chapter 11. Global Human Biospecimens Market, By Storage Type

11.1. Human Biospecimens Market Revenue and Volume, by Storage Type

11.1.1. Cold Storage (−80°C or LN2)

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Ambient/Room Temperature Stabilized

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Cryogenic (Liquid Nitrogen, −196°C)

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Formalin-Fixed Storage

11.1.4.1. Market Revenue and Volume Forecast

Chapter 12. Global Human Biospecimens Market, By Procurement Type

12.1. Human Biospecimens Market Revenue and Volume, by Procurement Type

12.1.1. Prospective Collection (On-Demand Collection)

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Retrospective/Banked Samples

12.1.2.1. Market Revenue and Volume Forecast

Chapter 13. Global Human Biospecimens Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Specimen Type

13.1.2. Market Revenue and Volume Forecast, by Application

13.1.3. Market Revenue and Volume Forecast, by End Use

13.1.4. Market Revenue and Volume Forecast, by Storage Type

13.1.5. Market Revenue and Volume Forecast, by Procurement Type

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Specimen Type

13.1.6.2. Market Revenue and Volume Forecast, by Application

13.1.6.3. Market Revenue and Volume Forecast, by End Use

13.1.6.4. Market Revenue and Volume Forecast, by Storage Type

13.1.6.5. Market Revenue and Volume Forecast, by Procurement Type

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Specimen Type

13.1.7.2. Market Revenue and Volume Forecast, by Application

13.1.7.3. Market Revenue and Volume Forecast, by End Use

13.1.7.4. Market Revenue and Volume Forecast, by Storage Type

13.1.7.5. Market Revenue and Volume Forecast, by Procurement Type

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Specimen Type

13.2.2. Market Revenue and Volume Forecast, by Application

13.2.3. Market Revenue and Volume Forecast, by End Use

13.2.4. Market Revenue and Volume Forecast, by Storage Type

13.2.5. Market Revenue and Volume Forecast, by Procurement Type

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Specimen Type

13.2.6.2. Market Revenue and Volume Forecast, by Application

13.2.6.3. Market Revenue and Volume Forecast, by End Use

13.2.7. Market Revenue and Volume Forecast, by Storage Type

13.2.8. Market Revenue and Volume Forecast, by Procurement Type

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Specimen Type

13.2.9.2. Market Revenue and Volume Forecast, by Application

13.2.9.3. Market Revenue and Volume Forecast, by End Use

13.2.10. Market Revenue and Volume Forecast, by Storage Type

13.2.11. Market Revenue and Volume Forecast, by Procurement Type

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Specimen Type

13.2.12.2. Market Revenue and Volume Forecast, by Application

13.2.12.3. Market Revenue and Volume Forecast, by End Use

13.2.12.4. Market Revenue and Volume Forecast, by Storage Type

13.2.13. Market Revenue and Volume Forecast, by Procurement Type

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Specimen Type

13.2.14.2. Market Revenue and Volume Forecast, by Application

13.2.14.3. Market Revenue and Volume Forecast, by End Use

13.2.14.4. Market Revenue and Volume Forecast, by Storage Type

13.2.15. Market Revenue and Volume Forecast, by Procurement Type

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Specimen Type

13.3.2. Market Revenue and Volume Forecast, by Application

13.3.3. Market Revenue and Volume Forecast, by End Use

13.3.4. Market Revenue and Volume Forecast, by Storage Type

13.3.5. Market Revenue and Volume Forecast, by Procurement Type

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Specimen Type

13.3.6.2. Market Revenue and Volume Forecast, by Application

13.3.6.3. Market Revenue and Volume Forecast, by End Use

13.3.6.4. Market Revenue and Volume Forecast, by Storage Type

13.3.7. Market Revenue and Volume Forecast, by Procurement Type

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Specimen Type

13.3.8.2. Market Revenue and Volume Forecast, by Application

13.3.8.3. Market Revenue and Volume Forecast, by End Use

13.3.8.4. Market Revenue and Volume Forecast, by Storage Type

13.3.9. Market Revenue and Volume Forecast, by Procurement Type

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Specimen Type

13.3.10.2. Market Revenue and Volume Forecast, by Application

13.3.10.3. Market Revenue and Volume Forecast, by End Use

13.3.10.4. Market Revenue and Volume Forecast, by Storage Type

13.3.10.5. Market Revenue and Volume Forecast, by Procurement Type

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Specimen Type

13.3.11.2. Market Revenue and Volume Forecast, by Application

13.3.11.3. Market Revenue and Volume Forecast, by End Use

13.3.11.4. Market Revenue and Volume Forecast, by Storage Type

13.3.11.5. Market Revenue and Volume Forecast, by Procurement Type

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Specimen Type

13.4.2. Market Revenue and Volume Forecast, by Application

13.4.3. Market Revenue and Volume Forecast, by End Use

13.4.4. Market Revenue and Volume Forecast, by Storage Type

13.4.5. Market Revenue and Volume Forecast, by Procurement Type

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Specimen Type

13.4.6.2. Market Revenue and Volume Forecast, by Application

13.4.6.3. Market Revenue and Volume Forecast, by End Use

13.4.6.4. Market Revenue and Volume Forecast, by Storage Type

13.4.7. Market Revenue and Volume Forecast, by Procurement Type

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Specimen Type

13.4.8.2. Market Revenue and Volume Forecast, by Application

13.4.8.3. Market Revenue and Volume Forecast, by End Use

13.4.8.4. Market Revenue and Volume Forecast, by Storage Type

13.4.9. Market Revenue and Volume Forecast, by Procurement Type

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Specimen Type

13.4.10.2. Market Revenue and Volume Forecast, by Application

13.4.10.3. Market Revenue and Volume Forecast, by End Use

13.4.10.4. Market Revenue and Volume Forecast, by Storage Type

13.4.10.5. Market Revenue and Volume Forecast, by Procurement Type

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Specimen Type

13.4.11.2. Market Revenue and Volume Forecast, by Application

13.4.11.3. Market Revenue and Volume Forecast, by End Use

13.4.11.4. Market Revenue and Volume Forecast, by Storage Type

13.4.11.5. Market Revenue and Volume Forecast, by Procurement Type

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Specimen Type

13.5.2. Market Revenue and Volume Forecast, by Application

13.5.3. Market Revenue and Volume Forecast, by End Use

13.5.4. Market Revenue and Volume Forecast, by Storage Type

13.5.5. Market Revenue and Volume Forecast, by Procurement Type

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Specimen Type

13.5.6.2. Market Revenue and Volume Forecast, by Application

13.5.6.3. Market Revenue and Volume Forecast, by End Use

13.5.6.4. Market Revenue and Volume Forecast, by Storage Type

13.5.7. Market Revenue and Volume Forecast, by Procurement Type

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Specimen Type

13.5.8.2. Market Revenue and Volume Forecast, by Application

13.5.8.3. Market Revenue and Volume Forecast, by End Use

13.5.8.4. Market Revenue and Volume Forecast, by Storage Type

13.5.8.5. Market Revenue and Volume Forecast, by Procurement Type

Chapter 14. Company Profiles

14.1. BioIVT

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Precision for Medicine

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. BioChain Institute Inc.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Conversant Bio (part of Discovery Life Sciences)

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Indivumed GmbH

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. REPROCELL Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. US Biolab Corporation, Inc.

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Biobank Graz (Medical University of Graz)

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. ProteoGenex Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Seracare Life Sciences (part of LGC Group)

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The human biospecimens market size is expected to increase from USD 12.42 billion in 2024 to USD 26.45 billion by 2034.

The human biospecimens market is expected to grow at a compound annual growth rate (CAGR) of around 7.85% from 2025 to 2034.

The major players in the human biospecimens market include BioIVT, Precision for Medicine, BioChain Institute Inc., Conversant Bio (part of Discovery Life Sciences), Indivumed GmbH, REPROCELL Inc., US Biolab Corporation, Inc., Biobank Graz (Medical University of Graz), ProteoGenex Inc., Seracare Life Sciences (part of LGC Group), Asterand Bioscience, OriGene Technologies, Inc., Biomax Informatics AG, Tissue Solutions Ltd., Human BioMolecular Research Institute (HBRI), AMS Bio (AMS Biotechnology), National Disease Research Interchange (NDRI), IQVIA (Biospecimen Services), Boca Biolistics, and BioRepository Inc.

The driving factors of the human biospecimens market are the growing due to increasing demand for personalized medicine, biomedical research, and advancements in diagnostic and drug development technologies.

North America region will lead the global human biospecimens market during the forecast period 2025 to 2034.